PBLs from SM patients exhibited significantly higher SP-triggered PGD2 release (2079 ± 207.2 pg/ml; P = 0.0205; Figure 5A) than PBLs from MCAS patients (1743 ± 446.0 pg/ml; Figure 5A). The gene discussed is PTGDS; the disease is systemic mastocytosis.